Literature DB >> 17530479

Genetic heterogeneity of Fasciola hepatica isolates in the northwest of Spain.

M P Vara-Del Río1, H Villa, M Martinez-Valladares, F A Rojo-Vázquez.   

Abstract

The liver fluke Fasciola hepatica is a worldwide distributed trematode parasite of great veterinary importance. In Spain, the prevalence of the infection is up to 56% in sheep. Its control is mainly based on the use of anthelmitics, although some resistant populations have been described. Genetic studies of the genus Fasciola have been focused on the 28S ribosomal deoxyribonucleic acid (rDNA) gene, with no intraspecific variations and a few interspecific nucleotide differences. We have designed a specific polymerase chain reaction to amplify and sequence a 510-bp-long fragment of the gene to characterize several F. hepatica ovine isolates from the northwest of Spain. All the isolates rendered the expected results on the agarose gel, while sequencing revealed some differences in the 34 site. The anthelmintic-resistant specimens showed the same nucleotide differing of the sensitive ones. Comparing to other studies, our results conclude that there are some genetic variations in F. hepatica (at the level of the 28S rDNA), including heterozygous specimens. In conclusion, a genetic heterogeneity has been found in the F. hepatica populations of ovine origin in the northwest of Spain, using an assay that could be useful for further epidemiology and characterization studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17530479     DOI: 10.1007/s00436-007-0574-z

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  8 in total

1.  A PCR-RFLP assay for the distinction between Fasciola hepatica and Fasciola gigantica.

Authors:  A Marcilla; M D Bargues; S Mas-Coma
Journal:  Mol Cell Probes       Date:  2002-10       Impact factor: 2.365

2.  An experimental study on triclabendazole resistance of Fasciola hepatica in sheep.

Authors:  C P Gaasenbeek; L Moll; J B Cornelissen; P Vellema; F H Borgsteede
Journal:  Vet Parasitol       Date:  2001-02       Impact factor: 2.738

3.  Seroprevalence of Fasciola hepatica infection in sheep in northwestern Spain.

Authors:  I Ferre; L M Ortega-Mora; F A Rojo-Vázquez
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

4.  Molecular evidence of natural hybridization between Fasciola hepatica and F. gigantica.

Authors:  T Agatsuma; Y Arakawa; M Iwagami; Y Honzako; U Cahyaningsih; S Y Kang; S J Hong
Journal:  Parasitol Int       Date:  2000-09       Impact factor: 2.230

5.  Characterisation of a beta-tubulin gene from the liver fluke, Fasciola hepatica.

Authors:  M W Robinson; E M Hoey; I Fairweather; J P Dalton; S McGonigle; A Trudgett
Journal:  Int J Parasitol       Date:  2001-09       Impact factor: 3.981

6.  Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole.

Authors:  M W Robinson; A Trudgett; E M Hoey; I Fairweather
Journal:  Parasitology       Date:  2002-03       Impact factor: 3.234

7.  The effect of the microtubule inhibitor tubulozole-C on the tegument of triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

Authors:  Mark W Robinson; Alan Trudgett; Elizabeth M Hoey; Ian Fairweather
Journal:  Parasitol Res       Date:  2003-08-09       Impact factor: 2.289

8.  Triploid form of Fasciola in Japan: genetic relationships between Fasciola hepatica and Fasciola gigantica determined by ITS-2 sequence of nuclear rDNA.

Authors:  T Itagaki; K Tsutsumi
Journal:  Int J Parasitol       Date:  1998-05       Impact factor: 3.981

  8 in total
  8 in total

1.  Intraspecific mitochondrial DNA variation of Fasciola hepatica eggs from sheep with different level of anthelmintic resistance.

Authors:  María Martínez-Valladares; Francisco A Rojo-Vázquez
Journal:  Parasitol Res       Date:  2014-05-16       Impact factor: 2.289

2.  Genetic characterization of Fasciola gigantica from different geographical regions of India by ribosomal DNA markers.

Authors:  O K Raina; Siju Susan Jacob; M Sankar; D Bhattacharya; S Bandyopadyay; Anju Varghese; Jayanta Kumar Chamuah; H Lalrinkima
Journal:  J Parasit Dis       Date:  2013-03-09

3.  Genetic identification of Fasciola hepatica by ITS-2 sequence of nuclear ribosomal DNA in Turkey.

Authors:  Ahmet Erensoy; Salih Kuk; Mehmet Ozden
Journal:  Parasitol Res       Date:  2009-03-17       Impact factor: 2.289

4.  Genetic variability among Fasciola hepatica samples from different host species and geographical localities in Spain revealed by the novel SRAP marker.

Authors:  S Alasaad; Q Y Li; R Q Lin; P Martín-Atance; J E Granados; P Díez-Baños; J M Pérez; X Q Zhu
Journal:  Parasitol Res       Date:  2008-06       Impact factor: 2.289

5.  Genetic characterisation of Fasciola samples from different host species and geographical localities revealed the existence of F. hepatica and F. gigantica in Niger.

Authors:  H Ali; L Ai; H Q Song; S Ali; R Q Lin; B Seyni; G Issa; X Q Zhu
Journal:  Parasitol Res       Date:  2008-01-09       Impact factor: 2.289

6.  Molecular identification of Fasciola spp. (Digenea: Fasciolidae) in Egypt.

Authors:  Y Dar; S Amer; A Mercier; B Courtioux; G Dreyfuss
Journal:  Parasite       Date:  2012-05       Impact factor: 3.000

Review 7.  Genetic characterization, species differentiation and detection of Fasciola spp. by molecular approaches.

Authors:  Lin Ai; Mu-Xin Chen; Samer Alasaad; Hany M Elsheikha; Juan Li; Hai-Long Li; Rui-Qing Lin; Feng-Cai Zou; Xing-Quan Zhu; Jia-Xu Chen
Journal:  Parasit Vectors       Date:  2011-06-10       Impact factor: 3.876

8.  Low genetic diversity in wide-spread Eurasian liver fluke Opisthorchis felineus suggests special demographic history of this trematode species.

Authors:  Ilja I Brusentsov; Alexey V Katokhin; Irina V Brusentsova; Sergei V Shekhovtsov; Sergei N Borovikov; Grigoriy G Goncharenko; Lyudmila A Lider; Boris V Romashov; Olga T Rusinek; Samat K Shibitov; Marat M Suleymanov; Andrey V Yevtushenko; Viatcheslav A Mordvinov
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.